As a member of the Corporate and Securities Practice Group, Jason Balog has built a diverse practice focusing on the representation of clients in general business matters, commercial transactions and corporate mergers and acquisitions. His clients range from start-ups, to closely-held businesses, to Fortune 500 companies. Jason is co-leader of the firm's Mergers and Acquisitions Practice Area Team. Jason is an established business transaction advisor that regularly represents middle market companies in mergers and acquisitions and joint venture arrangements. He has also represented a number of companies based outside of the U.S. regarding domestic and cross-border merger and acquisition transactions as well as complex restructurings. Jason often works with sellers of closely-held companies in the sale of their companies to strategic investors or private equity buyers. Jason serves as general corporate counsel for many businesses overseeing all aspects of corporate planning and business advisory services. He is well versed in private equity and venture capital investments, financing transactions, and general corporate planning. Jason also counsels clients in wide variety of corporate matters including, entity formation, corporate governance, tax-based planning, business operations, production agreements, product development, marketing and advertising development, product packaging, retail sales promotions and contests, contractual agreements, confidentiality agreements, supply and distribution agreements, disclosure agreements, technology development and licensing, outsourcing, strategic alliance and teaming arrangements, consulting and service agreements, and distributor/dealer relationships. Industry Focus: Jason has completed transactions and represented clients across numerous industries including, all aspects of manufacturing, warehousing and distribution, life sciences, biotechnology and pharmaceuticals, government contracting, professional services, direct marketing and sales, retail, waste disposal and recycling, engineering and construction, technology and innovative sciences. Credentials American Bar Association: Business Law Section Baltimore SmartCEO Magazine: 'Legal Elite' (2010) Greater Baltimore Committee: Bio Science Committee Greater Baltimore Tech Council Publications "Economic Woes and the Biotechnology Industry," The Frederick News-Post (Balog's Biotech Column) (August 30, 2009). "Battle Over Biosimilars," The Frederick News-Post (Balog's Biotech Column) (August 2, 2009). "Focus on BioMaryland 2020," The Frederick News-Post (Balog's Biotech Column) (June 28, 2009). "Postcard From BIO," The Frederick News-Post (Balog's Biotech Column) (May 31, 2009). "Defending Bioscience Funding During Tough Economic Times," The Frederick News-Post (Balog's Biotech Column) (May 3, 2009). "Stem Cell Funding Reversal: Any Immediate Effect For Maryland," The Frederick News-Post (Balog's Biotech Column) (March 29, 2009). "Prominent Institutions, Discoveries Anchor Region's Industry," The Frederick News-Post (Balog's Biotech Column) (February 22, 2009). "Just Layoffs or Something More?" The Frederick News-Post (Balog's Biotech Column) (January 25, 2009). "Difficult Economic Times May Affect Future Innovation," The Frederick News-Post (Balog's Biotech Column) (Balog's Biotech) (December 28, 2008). "Putting State Money to Good Use," The Frederick News-Post (Balog's Biotech Column) (November 30, 2008). "Mid-Atlantic Bio 2008," The Frederick News-Post (Balog's Biotech Column) (October 26, 2008). "Biotech deals in 2008: Not as bad as you might think," The Frederick News-Post (Balog's Biotech Column) (September 28, 2008). "Time is Right for Investment of Pension Funds in Maryland's Bioscience Industry," The Frederick News-Post (Balog's Biotech Column) (August 31, 2008). "Crazy for Credits," The Frederick News-Post (Balog's Biotech Column) (July 27, 2008). "Dissecting O'Malley's Bio 2020 Initiative," The Frederick News-Post (Balog's Biotech Column) (June 29, 2008). "Maryland's Life Sciences Advisory Board makes progress in its strategic plan," The Frederick News-Post (Balog's Biotech Column) (May 25, 2008). "Looking Back on the Legislative Session," The Frederick News-Post (Balog's Biotech Column) (April 27, 2008). "Stem Cell Research Fund," The Frederick News-Post (Balog's Biotech Column) (March 23, 2008). "Acquisition: Good or Bad" The Frederick News-Post (Balog's Biotech Column) (February 24, 2008). "Time is Right to Invest Pension Funds in Bioscience Industry," The Daily Record's Bioscience Supplement: The Biotech Report (February 2008). "Maryland Biotechnology Investment Tax Credit: Worth the Investment?" The Frederick News-Post (Balog's Biotech Column) (January 27, 2008). "Don't Worry, Be Happy: The Effect of Recent Acquisitions on Maryland's Biotech Industry," The Baltimore Business Journal (July 20, 2007). "Beyond Intellectual Property: Other Legal Challenges for the Life Sciences Entrepreneur," The Daily Record's Bioscience Supplement: The Maryland Biotech Boom (February 2007). Speaking Engagements "Turn the Key on Your Startup - Getting Your Business Up and Running," Frederick Innovative Technology Center - Fall Lecture Series, Frederick, Maryland (Panelist) (October 16, 2008). "Organizing the Company," MICPEL Small Business Institute, Columbia Maryland (Program Chairman and Panelist) (March 19, 2008). "Best Steps for the Entrepreneur?" American Chemical Society, Annual Meeting, Boston, Massachusetts (Panelist) (August 21, 2007). |